ArticleInternational health2026
Barriers in managing maternal schistosomiasis: a qualitative study of healthcare providers in Tanzania.
Article in International health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMaternal schistosomiasis threatens the health of pregnant women and their foetuses in endemic regions. Although praziquantel is recommended for treatment, its utilization remains low. This study explored the experiences of healthcare providers (HCPs) with schistosomiasis, particularly maternal schistosomiasis, and their perceived management barriers in Tanzania.
methodsThis qualitative case study was conducted in October 2024 with nine purposefully selected HCPs. In-depth interviews guided by a semi-structured tool analysed HCPs' experiences with schistosomiasis, maternal schistosomiasis and perceived management barriers. Interviews were audio recorded, transcribed verbatim and thematically analysed to identify key insights and barriers.
resultsBarriers to maternal schistosomiasis management were identified across three levels. At the policy level, the absence of guidance on diagnosis, treatment and prophylaxis in maternal health guidelines, along with the exclusion of pregnant women from mass drug administration programs, were prominent. Health system barriers included limited knowledge and training among HCPs and concerns about praziquantel safety in pregnancy. At the community level, inadequate health education, misconceptions, reliance on drug outlets and negative perceptions of praziquantel further impeded effective management.
conclusionsMaternal schistosomiasis management in Tanzania is hindered by policy gaps, limited HCP training and community misconceptions. Integrating care into antenatal services, updating guidelines and strengthening community education are essential in endemic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.